⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 5, 2021Journal of Clinical MicrobiologyOpen Access

Prevalence of bla CTX-M Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States

Pranita D. Tamma Tiffeny T. Smith Ayomikun Adebayo Sara M. Karaba Emily Jacobs Teresa Wakefield Thi Hoang Duong Nguyen Natalie N. Whitfield Patricia J. Simner

View Full Paper

Ask AI

Bookmark

Share

Abstract

Understanding bacterial species at highest risk for harboring bla CTX-M genes is necessary to guide antibiotic treatment. We identified the species-specific prevalence of bla CTX-M genes in clinical isolates from the United States.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tamma et al. (2021) studied this question.

synapsesocial.com/papers/6a95d7029e192b00ba376db0 https://doi.org/10.1128/jcm.00127-21

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017Survey · 2020 · 575 citations
2Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotypeNarrative Review · 2017 · 792 citations
3Epidemiology and Risk Factors for Isolation of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in a Large U.S. Medical CenterRetrospective Study · 2013 · 74 citations
4Molecular Characterization of Baseline Enterobacterales and Pseudomonas aeruginosa Isolates from a Phase 3 Nosocomial Pneumonia (ASPECT-NP) Clinical TrialHuman Clinical Trial · 2020 · 17 citations
5Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent IsolatesRetrospective Study · 2015 · 82 citations

More related papers

Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing <i>Enterobacter cloacae</i> : Role of Carbapenem Therapy2010
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and<i>Pseudomonas aeruginosa</i>with Difficult-to-Treat Resistance (DTR-<i>P. aeruginosa</i>)2021
Molecular Epidemiology of Ceftriaxone-Nonsusceptible Enterobacterales Isolates in an Academic Medical Center in the United States2019

More from Journal of Clinical Microbiology

Performance evaluation of antimicrobial susceptibility testing devices across CLSI, EUCAST, ISO, FDA, and EMA frameworks: implications for breakpoint applicationTue,
Comparison of antimicrobial susceptibility testing methods for aztreonam-avibactam against NDM-producing Enterobacterales clinical isolatesMon,